These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34728106)

  • 21. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.
    Muthu V; Kumar M; Paul RA; Zohmangaihi D; Choudhary H; Rudramurthy SM; Panda NK; Pannu AK; Sharma N; Sharma S; Chakrabarti A; Agarwal R
    Mycoses; 2021 Oct; 64(10):1291-1297. PubMed ID: 34420245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.
    Biswal M; Gupta P; Kanaujia R; Kaur K; Kaur H; Vyas A; Hallur V; Behera B; Padaki P; Savio J; Nagaraj S; Chunchanur SK; Shwetha JV; Ambica R; Nagdeo N; Khuraijam R; Priyolakshmi N; Patel K; Thamke D; Dash L; Jadhav D; Bharmal R; Bhattacharya S; Rudramurthy SM; Chakrabarti A
    J Hosp Infect; 2022 Apr; 122():173-179. PubMed ID: 35124141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept.
    Garg P; Mittal S
    Diabetes Metab Syndr; 2021; 15(4):102177. PubMed ID: 34198108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis.
    Singh R; Kumari A
    ACS Infect Dis; 2021 Aug; 7(8):2211-2213. PubMed ID: 34328718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
    Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
    Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucormycosis: An unanticipated progeny of COVID-19.
    Shrestha GS; Bhandari S; Lamsal R; Gurung U
    JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping.
    Hussain S; Baxi H; Riad A; Klugarová J; Pokorná A; Slezáková S; Líčeník R; Najmi AK; Klugar M
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
    Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
    Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case-control study.
    Muthu V; Dhaliwal M; Sharma A; Nair D; Kumar HM; Rudramurthy SM; Sehgal IS; Choudhary H; Panda N; Chakrabarti A; Agarwal R
    Mycopathologia; 2022 Aug; 187(4):355-362. PubMed ID: 35727491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients.
    Ramaswami A; Sahu AK; Kumar A; Suresh S; Nair A; Gupta D; Chouhan R; Bhat R; Mathew R; Majeed JA; Aggarwal P; Nayer J; Ekka M; Thakar A; Singh G; Xess I; Wig N
    QJM; 2021 Nov; 114(7):464-470. PubMed ID: 34254132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
    Garg D; Muthu V; Sehgal IS; Ramachandran R; Kaur H; Bhalla A; Puri GD; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 May; 186(2):289-298. PubMed ID: 33544266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports.
    Gogineni H; So W; Mata K; Greene JN
    Egypt J Intern Med; 2022; 34(1):58. PubMed ID: 35911783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
    Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
    Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.